SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-035314
Filing Date
2024-11-14
Accepted
2024-11-14 16:16:03
Documents
69
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q allr20240930_10q.htm   iXBRL 10-Q 2144120
2 EXHIBIT 31.1 ex_729176.htm EX-31.1 12546
3 EXHIBIT 31.2 ex_729177.htm EX-31.2 12554
4 EXHIBIT 32.1 ex_729178.htm EX-32.1 6858
  Complete submission text file 0001437749-24-035314.txt   9422238

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA allr-20240930.xsd EX-101.SCH 63944
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE allr-20240930_cal.xml EX-101.CAL 34395
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE allr-20240930_def.xml EX-101.DEF 456042
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE allr-20240930_lab.xml EX-101.LAB 374186
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE allr-20240930_pre.xml EX-101.PRE 488829
72 EXTRACTED XBRL INSTANCE DOCUMENT allr20240930_10q_htm.xml XML 1593232
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41160 | Film No.: 241462577
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)